Hyperglycemia and Oxidative Stress in the Human Brain With Diabetes
Primary Purpose
Type 2 Diabetes
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Vitamin C
Sponsored by
About this trial
This is an interventional basic science trial for Type 2 Diabetes focused on measuring Diabetes, Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria:
- Good health except for having type 2 diabetes
- Being treated with diet, insulin, or oral hyperglycemic agents
- Male or non pregnant female
- Non-smoker
- HbA1c 8 or above
- Able to provide informed consent
Exclusion Criteria:
- Presence of mental illness
- Co-existing chronic inflammatory condition or neurological disease or diseases associated with abnormal glutathione metabolism
- BMI over 35
- Smoker
Sites / Locations
- University of Kansas Medical Center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Vitamin C
Arm Description
2 gms vitamin C
Outcomes
Primary Outcome Measures
MRI, mRS, urine and blood samples
Secondary Outcome Measures
7 day food and DHQ food questionnaire
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00775541
Brief Title
Hyperglycemia and Oxidative Stress in the Human Brain With Diabetes
Official Title
Hyperglycemia and Oxidative Stress in the Human Brain With Diabetes
Study Type
Interventional
2. Study Status
Record Verification Date
June 2012
Overall Recruitment Status
Terminated
Why Stopped
Insufficient dose for MRI scanning
Study Start Date
October 2007 (undefined)
Primary Completion Date
August 2009 (Actual)
Study Completion Date
August 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
In-Young Choi, Ph.D.
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to use an MRI exam to measure the concentrations of glutathione (GSH) and Vitamin C (Asc) in the brains of normal healthy persons and type 2 diabetic persons. The study will look at the relationship between chronic hyperglycemia and the levels of these naturally occurring chemicals in the brain.
Detailed Description
Cerebral GSH and Asc concentrations are modulated by increased oxidative stress induced by hyperglycemia in diabetes and reflect changes in the cerebral antioxidant defense system. Inhibition of cellular uptake of Asc by hyperglycemia further hampers maintaining adequate antioxidant capacities. Reduced concentrations of these antioxidants might serve as good indicators of increased susceptibility to oxidative damage, impaired cellular uptake or the antioxidant, and further, as sensitive in vivo biomarkers to assess early manifestations or progression of diabetic complications and the efficacy of the antioxidant therapy in the human brain. Specific aims (1) to determine cerebral concentrations of GSH and Asc in the living brain of healthy controls and type 2 diabetic patients; (2) to quantify the effect of chronic hyperglycemia on cellular uptake of Asc across the blood-brain barrier.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
Keywords
Diabetes, Type 2 Diabetes
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
5 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Vitamin C
Arm Type
Experimental
Arm Description
2 gms vitamin C
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin C
Intervention Description
One IV infusion of 2 gm vitamin C
Primary Outcome Measure Information:
Title
MRI, mRS, urine and blood samples
Time Frame
before and after IV infusion, 6 hours
Secondary Outcome Measure Information:
Title
7 day food and DHQ food questionnaire
Time Frame
7 days prior to MRI and vitamin C infusion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Good health except for having type 2 diabetes
Being treated with diet, insulin, or oral hyperglycemic agents
Male or non pregnant female
Non-smoker
HbA1c 8 or above
Able to provide informed consent
Exclusion Criteria:
Presence of mental illness
Co-existing chronic inflammatory condition or neurological disease or diseases associated with abnormal glutathione metabolism
BMI over 35
Smoker
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
In-Young Choi, PhD
Organizational Affiliation
University of Kansas Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Kansas Medical Center
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Hyperglycemia and Oxidative Stress in the Human Brain With Diabetes
We'll reach out to this number within 24 hrs